According to Valuates Reports, The global Optical Quantum Computing Platform market was valued at USD 4715 Million in 2023 and is anticipated to reach USD 29640 Million by 2030, witnessing a CAGR of ...
The market opportunities for TL1A Inhibitors and DR3 Antagonists focus on their potential to address inflammatory bowel disease, evidenced by heightened interest from major pharmaceutical companies.
Preclinical AVB-406 data presented in three oral presentations demonstrate the power of the vMiXTM RNAi platform and support ...
MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious ...
A long‑overlooked stretch of the human genome appears to play a distinct role in shaping the social and stereotypic ...
Oscar Wilde’s battle of the sexes becomes a dazzlingly funny free-for-all in this gloriously gender-bent production.
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635) ("PPS"), has officially unveiled a ...
METiS TechBio (7666.HK), a tech-bio company focused on AI-powered nanodelivery innovation, today successfully listed on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results